Our present study explored the feasibility of using the multiple flip angle approach to estimate kio during treatment of murine glioma using a combination therapy of bevacizumab, a monoclonal antibody against VEGF, and fluorouracil (5FU), a cytotoxic chemotherapeutic agent. Here, VEGFA is linked to central nervous system cancer.